Related Experiment Videos
The beneficial effect of statins treatment by stroke subtype
P Martínez-Sánchez1, C Rivera-Ordóñez, B Fuentes
1Stroke Unit, Department of Neurology, Hospital Universitario La Paz, Universidad Autónoma de Madrid, Madrid, Spain.
Insights
Statins improve outcomes for ischemic stroke patients, particularly those with atherothrombotic and lacunar strokes. This study confirms statin use as a predictor of good functional status at discharge.
Area of Science:
- Neurology
- Cardiovascular Medicine
- Clinical Research
Background:
- Observational studies suggest statins offer protection post-ischemic stroke.
- The impact of statins on specific etiological stroke subtypes remains unexamined.
Purpose of the Study:
- To investigate the association between pre-stroke statin use and patient outcomes.
- To determine if statin benefits vary across different ischemic stroke subtypes.
Main Methods:
- Analysis of data from 2742 consecutive ischemic stroke patients in the Stroke Unit Data Bank.
- Logistic regression models assessed the association between statin use and functional status at discharge (modified Rankin Scale).
- Adjustments were made for demographic data, cardiovascular risk factors, stroke severity, and other relevant variables.
Main Results:
- 10.2% of patients (281/2742) were on statins at admission.
- Pre-stroke statin use independently predicted better functional outcomes in all ischemic strokes (OR, 2.08).
- Significant benefits were observed in atherothrombotic (OR, 2.79) and lacunar strokes (OR, 2.28), but not in cardioembolic or other stroke types.
Conclusions:
- Pre-stroke statin therapy is an independent predictor of favorable outcomes in ischemic stroke patients.
- Atherothrombotic and small vessel (lacunar) strokes demonstrate the most significant benefit from statin use.
- Statin therapy may play a crucial role in improving recovery across specific ischemic stroke etiologies.
Background And Purpose:
Statins have shown some protective effect after ischaemic stroke in observational studies. However, this effect has never been assessed by etiological subtypes.
Methods:
Observational study using data from the Stroke Unit Data Bank from consecutive patients with cerebral infarction. Variables analyzed: demographic data, cardiovascular risk factors, treatment with statins at stroke onset, stroke severity, stroke subtype, in-hospital complications, length of stay, and functional status at discharge (modified Rankin Scale).
Results:
A total of 2742 patients were included, 1539 were men. Mean age was 69.17 years (SD 12.19). Of these, 281 patients (10.2%) were receiving statins when admitted. The logistic regression analyses showed that previous treatment with statins was an independent predictor for better outcome at discharge among all strokes (OR, 2.08; 95% CI, 1.39 to 3.1) as well as for the atherothrombotic (OR, 2.79; 95% CI, 1.33 to 5.84) and lacunar strokes (OR, 2.28; 95% CI, 1.15 to 4.52) after adjustment for demographic data, risk factors, previous treatments, stroke subtypes, stroke severity, in-hospital complications and length of stay. This benefit was not observed either in cardioembolic or in other etiology strokes.
Conclusions:
Previous treatment with statins is an independent factor associated with good outcomes in patients with ischaemic stroke. Atherothrombotic and small vessel strokes show the greatest benefit.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis III: Management
Ischemic Stroke l: Introduction
Ischemic Stroke ll: Pathophysiology
Stroke: Introduction and Types
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...